Skip to main content

JNJ

JOHNSON & JOHNSON
Sector
Health Care
Industry
Pharmaceuticals
Last price
$240.87
As of

Active signals for JNJ

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — JOHNSON An Efficacy and Safety Study of Tramadol/Acetaminophen Versus Diclofenac in the

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — JOHNSON A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Dise

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — JOHNSON To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Canc

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — JOHNSON A Study to Compare Safety and Efficacy of Osmotic Release Oral Syytem (OROS) Hyd

  • highTRIAL_TERMINATION

    Phase 3 trial terminated early — JOHNSON A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus P

Recent SEC filings, JNJ

Related tickers in Health Care

See more JNJ signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track JNJ in your watchlist and get notified the moment a new signal fires.

Track JNJ on Kresmion →